Terms: = Brain cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
101 results:
1. Stereotactic radiosurgery of brain metastases: a retrospective study.
Gruber I; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors.
Kaya M; Aksoy A; Artas G; Kaplan M
Ideggyogy Sz; 2023 Sep; 76(9-10):339-347. PubMed ID: 37782060
[TBL] [Abstract] [Full Text] [Related]
3. Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian cancer.
Leman R; Muller E; Legros A; Goardon N; Chentli I; Atkinson A; Tranchant A; Castera L; Krieger S; Ricou A; Boulouard F; Joly F; Boucly R; Dumont A; Basset N; Coulet F; Chevalier LM; Rouleau E; Leitner K; González-Martin A; Gargiulo P; Lück HJ; Genestie C; ; Ray-Coquard I; Pujade-Lauraine E; Vaur D
Clin Cancer Res; 2023 Nov; 29(21):4419-4429. PubMed ID: 37756555
[TBL] [Abstract] [Full Text] [Related]
4. Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta-analysis of real-world survival outcomes of East Asian patients with advanced non-small cell lung cancer treated with first-line EGFR-TKIs.
Chang HC; Wang CC; Tseng CC; Huang KT; Chen YM; Chang YP; Lai CH; Fang WF; Lin MC; Chuang HY
Thorac Cancer; 2023 Nov; 14(32):3208-3216. PubMed ID: 37737541
[TBL] [Abstract] [Full Text] [Related]
5. Association Between Pseudoprogression of Vestibular Schwannoma After Radiosurgery and Radiological Features of Solid and Cystic Components.
Huang CY; Peng SJ; Yang HC; Wu HM; Chen CJ; Wang MC; Hu YS; Lin CJ; Shiau CY; Guo WY; Chung WY; Pan DH; Lee CC
Neurosurgery; 2023 Dec; 93(6):1383-1392. PubMed ID: 37432016
[TBL] [Abstract] [Full Text] [Related]
6. Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.
Liu ZD; Wang SQ; Li S; He J; Wang SH; Cai HQ; Wan JH
Clinics (Sao Paulo); 2023; 78():100212. PubMed ID: 37201304
[TBL] [Abstract] [Full Text] [Related]
7. Health litigation and cancer survival in patients treated in the public health system in a large Brazilian city, 2014-2019.
de Castro MSM; da Silva GDM; Figueiredo IVO; de Miranda WD; Magalhães Júnior HM; Dos Santos FP; de Sousa RP
BMC Public Health; 2023 Mar; 23(1):534. PubMed ID: 36944943
[TBL] [Abstract] [Full Text] [Related]
8. Compassionate use of recombinant human IL-7-hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma.
Ahn S; Park JS; Kim H; Heo M; Sung YC; Jeun SS
Cancer Med; 2023 Mar; 12(6):6778-6787. PubMed ID: 36583472
[TBL] [Abstract] [Full Text] [Related]
9. Predictive Model to Guide brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung cancer: Impact on Real-World Outcomes.
Wu J; Ding V; Luo S; Choi E; Hellyer J; Myall N; Henry S; Wood D; Stehr H; Ji H; Nagpal S; Hayden Gephart M; Wakelee H; Neal J; Han SS
JCO Precis Oncol; 2022 Oct; 6():e2200220. PubMed ID: 36201713
[TBL] [Abstract] [Full Text] [Related]
10. Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Gu W; Han W; Luo H; Zhou F; He D; Ma L; Guo H; Liang C; Chong T; Jiang J; Chen Z; Wang Y; Zou Q; Tian Y; Xiao J; Huang J; Zhu S; Dong Q; Zhang X; Li H; Yang X; Chen C; Li J; Jin C; Zhang X; Ye D;
Lancet Oncol; 2022 Oct; 23(10):1249-1260. PubMed ID: 36075260
[TBL] [Abstract] [Full Text] [Related]
11. Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.
Chu WY; Allegaert K; Dorlo TPC; Huitema ADR;
Clin Pharmacokinet; 2022 Nov; 61(11):1545-1558. PubMed ID: 36040612
[TBL] [Abstract] [Full Text] [Related]
12. The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review.
Landes JR; Moore SA; Bartley BR; Doan HQ; Rady PL; Tyring SK
J Cancer Res Clin Oncol; 2023 May; 149(5):2139-2155. PubMed ID: 35941226
[TBL] [Abstract] [Full Text] [Related]
13. The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan.
Cheng WC; Shen YC; Chien CR; Liao WC; Chen CH; Hsia TC; Tu CY; Chen HJ
Thorac Cancer; 2022 May; 13(10):1505-1512. PubMed ID: 35394114
[TBL] [Abstract] [Full Text] [Related]
14. The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients.
de Marcellus C; Tauziède-Espariat A; Cuinet A; Pasqualini C; Robert MP; Beccaria K; Puget S; Boddaert N; Figarella-Branger D; De Carli E; Bourdeaut F; Leblond P; Fouyssac F; Andre N; Bertozzi AI; Butel T; Dufour C; Valteau-Couanet D; Varlet P; Grill J
J Neurooncol; 2022 Apr; 157(2):355-364. PubMed ID: 35239111
[TBL] [Abstract] [Full Text] [Related]
15. cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
[TBL] [Abstract] [Full Text] [Related]
16. Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity.
Doan P; Nguyen P; Murugesan A; Candeias NR; Yli-Harja O; Kandhavelu M
Cells; 2021 Aug; 10(8):. PubMed ID: 34440745
[TBL] [Abstract] [Full Text] [Related]
17. Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report.
Yaura K; Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
Tohoku J Exp Med; 2021 Aug; 254(4):253-256. PubMed ID: 34373422
[TBL] [Abstract] [Full Text] [Related]
18. Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism.
Alfardus H; de Los Angeles Estevez-Cebrero M; Rowlinson J; Aboalmaaly A; Lourdusamy A; Abdelrazig S; Ortori C; Grundy R; Kim DH; McIntyre A; Smith S
Sci Rep; 2021 Aug; 11(1):15908. PubMed ID: 34354095
[TBL] [Abstract] [Full Text] [Related]
19. Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis.
Revilla-Pacheco F; Rodríguez-Salgado P; Barrera-Ramírez M; Morales-Ruiz MP; Loyo-Varela M; Rubalcava-Ortega J; Herrada-Pineda T
Medicine (Baltimore); 2021 Jun; 100(25):e26432. PubMed ID: 34160432
[TBL] [Abstract] [Full Text] [Related]
20. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract] [Full Text] [Related]
[Next]
